25th Anniversary New Cardiovascular Horizons
May 28 – 31, 2024

Dates to Remember

2024 Javelin
Supplemental Abstract Issue will be uploaded after conference

  • Aug 26, 2023 – Abstract Submission Opens 
  • April 19, 2024– Abstract Submission Closes (at 5:00 PM Central Time) 
  • May 17, 2024 – Digital Posters Due (at 11:59 AM Central Time) 
  • May 28 – May 31, 2024– Conference Dates 
  • Aug 15, 2024 – Digital Archives and Proceedings Publication Available Online 

    For submissions and/or questions, contact abstracts@ncvh.org or 337.993.7920.

    Email notifications confirming receipt should be sent within 72 hours of submission.  Every attempt will be made to notify the primary author of acceptance status within two weeks of original submission so registration and travel arrangements can be accommodated in a timely manner.

    Accepted abstracts will be distributed via print format in the “Proceedings of New Cardiovascular Horizons 2024” publication. Complimentary copies will be available onsite at the conference May 28  – May 31, 2024 and can be downloaded in PDF format at HERE.

    Accepted abstracts will be presented in digital poster format on a touchscreen display. This all-digital format will allow for vivid graphics and looping videos to be imbedded into posters in addition to or in lieu of still photographs.  Click here to view a sample.

    Abstracts are not presented orally at this conference, however, if the course directors chose to add the abstract content for presentation during the CME program, you will receive a separate faculty invitation.

    Digital poster specifications for submission and display:

    • Size: 1920×960 (16:8 aspect ratio)
    • Format: PPTX (PowerPoint), PDF (with embedded fonts), PNG or JPG
    • Quality: 300 dpi
    • Videos: MP4 (send as an individual 30 second file and will be imbedded in poster on a loop)

    Primary authors for accepted abstracts will receive complimentary registration for the entire 3-day meeting.  Upon acceptance, a promo code will be emailed to the primary contact for use in our online registration system.

    The registration fee will be waived for fellows or residents with an accepted abstract following verification of active fellowship status from the program director.

    Content Guidelines

    Abstracts should address an area of cardiovascular disease, peripheral artery (or vascular) disease, diabetes, critical limb ischemia, podiatry, wound care and/or limb salvage. Content must constitute original research but may include portions of prior abstracts and/or manuscripts presented elsewhere. Clinical studies, basic investigation and animal studies are equally encouraged to be submitted for review.
     
    Abstracts must be submitted in English.
     
    You MUST include Title, Author(s), Author Affiliation(s) and Category data in your abstract before the actual text of the abstract. (See example template below)

    Abstracts must include: Background, Methods, Results and Conclusion.
    Submission Categories
    • Peripheral Artery Disease
    • Critical Limb Ischemia
    • Venous Disease
    • Cardiovascular Disease
    • Podiatry/Wound Care
    • Limb Salvage
    Abstract Title

    Abstract titles should be concise and should not contain abbreviations. The first letter of each word should be capitalized.

    Abstract Authors

    The submitting author is automatically designated as the primary/presenting author.

    Abstract Format

    Please submit a correctly formatted Microsoft Word Document, example provided below.

    Abstract Title

    John D. Smith, MD1; Joe M. Smith, MD2, John W. Doe, MD1

    Louisiana State University Medical Center, New Orleans, LA, USA1

    Southwest Medical Center, Lafayette, LA, USA2

    Category:

    Background:

    Methods:

    Results:

    Conclusion:

    • The maximum number of words allowed is 450 (title, authors, and affiliations do not count as part of the 450 words). The addition of a table deducts 50 words from the 450-word total.
    • Use zeros before decimal points: 0.05, not .05. Use decimal points, not commas: 0.05, not 0,05. Use lowercase “p” values (p<0.05).
    • Provide manufacturer name and location in parentheses for all brand or trade names. For brand drugs, include generic names in parentheses.
    • All abbreviations must be spelled out in parentheses the first time it is used. Do not include references, credits, or grant support.
    Abstract Withdrawal

    Requests for abstract withdrawals must be received electronically by  (at 11:59 PM Central Time). Withdrawal requests should be sent to: abstracts@ncvh.org.

    Abstract Review and Notification

    Abstracts are peer-reviewed by the NCVH peer-review committee selected by the NCVH course directors. All grading is blinded prior to peer-review.
      
    For questions regarding abstracts, please contact Tom Best at abstracts@ncvh.org or 337.993.7920.

    Sign up and stay connected with NCVH

    Sign up for the latest news & information on NCVH Annual Conference.

    By submitting this form, you are consenting to receive marketing emails from: New Cardiovascular Horizons, 3639 Ambassador Caffery Pkwy., Suite 605, Lafayette, LA, 70503 United States, http://www.ncvh.org/. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact.